Bora Pharmaceuticals Co., LTD. (6472.TW)

TWD 744.0

(-0.67%)

Net Debt Summary of Bora Pharmaceuticals Co., LTD.

  • Bora Pharmaceuticals Co., LTD.'s latest annual net debt in 2023 was 1.95 Billion TWD , down -54.68% from previous year.
  • Bora Pharmaceuticals Co., LTD.'s latest quarterly net debt in 2024 Q1 was 996.08 Million TWD , down -49.09% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported annual net debt of 4.31 Billion TWD in 2022, up 227.97% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported annual net debt of 1.31 Billion TWD in 2021, down -40.5% from previous year.
  • Bora Pharmaceuticals Co., LTD. reported quarterly net debt of 13.11 Billion TWD for 2024 Q2, up 1216.83% from previous quarter.
  • Bora Pharmaceuticals Co., LTD. reported quarterly net debt of 1.95 Billion TWD for 2023 Q4, down -27.0% from previous quarter.

Annual Net Debt Chart of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Historical Annual Net Debt of Bora Pharmaceuticals Co., LTD. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 1.95 Billion TWD -54.68%
2022 4.31 Billion TWD 227.97%
2021 1.31 Billion TWD -40.5%
2020 2.21 Billion TWD 131.26%
2019 956.63 Million TWD 0.0%

Peer Net Debt Comparison of Bora Pharmaceuticals Co., LTD.

Name Net Debt Net Debt Difference
Grape King Bio Ltd -4.62 Billion TWD 142.297%
Standard Chem & Pharm CO., LTD. -954.74 Million TWD 304.93%
Maywufa Company Ltd. 264.18 Million TWD -640.6%
ScinoPharm Taiwan, Ltd. -3.32 Billion TWD 158.925%
Lotus Pharmaceutical Co., Ltd. 9.81 Billion TWD 80.063%
LIWANLI Innovation Co., Ltd. -244.02 Million TWD 901.791%
YungShin Global Holding Corporation -247.5 Million TWD 890.524%
PhytoHealth Corporation -34.64 Million TWD 5748.088%
SCI Pharmtech, Inc. 100.41 Million TWD -1848.429%
Formosa Laboratories, Inc. 2.53 Billion TWD 22.922%
PharmaEssentia Corporation -18.46 Billion TWD 110.596%